Background COVID-19 is a viral prothrombotic respiratory infection. Heparins exert
antithrombotic and anti-inflammatory effects, and might have antiviral properties. We aimed to …

Background: A clear patency benefit of a drug-eluting stent (DES) over bare metal stents (BMSs)
for treating peripheral artery disease of the femoropopliteal segment has not been …

Arterial and venous thrombosis constitute a major source of morbidity and mortality worldwide.
Association between thrombotic complications and cardiovascular and other chronic …

Heparins are widely used for prophylaxis and treatment of thromboembolic diseases. Besides
bleeding complications, heparin-induced skin lesions are the most frequent unwanted …

Multiple factors contribute to the risk of venous thromboembolism (VTE). Platelets have attracted
much interest in arterial cardiovascular disease, whereas their role in VTE has received …

Atherosclerosis, a lipid‐driven inflammatory disease, is the main underlying cause of
cardiovascular diseases (CVDs) both in men and women. Sex‐related dimorphisms regarding …

Atherosclerotic vascular disease remains the most common cause of ischemia, myocardial
infarction, and stroke. Vascular function is determined by structural and functional properties …

Thrombophilia is a well‐established risk factor for a venous thromboembolic event ( VTE ),
and it has been proposed that hereditary thrombophilia may substantially contribute to the …

Background: Little is known about the incidence and causes of heparin-induced skin lesions.
The 2 most commonly reported causes of heparin-induced skin lesions are immune-…

Background : Life-threatening heparin-induced thrombocytopenia (HIT) is treated with the
alternative nonheparin anticoagulants argatroban, lepirudin, or danaparoid. Frequently, the …